Senvest Management’s Teva Pharmaceuticals TEVA Stock Holding History

Senvest Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,028	Closed	-$415K	–	96
2015 Q2	$415K	Hold	7,028	–	–	0.03%	83
2015 Q1	$438K	Hold	7,028	–	–	0.03%	86
2014 Q4	$404K	Hold	7,028	–	–	0.03%	72
2014 Q3	$378K	Hold	7,028	–	–	0.04%	75
2014 Q2	$368K	Buy	+7,028	New	+$359K	0.03%	78
2013 Q4	–	Sell	-77,583	Closed	-$2.93M	–	103
2013 Q3	$2.93M	Hold	77,583	–	–	0.33%	43
2013 Q2	$3.04M	Buy	+77,583	New	+$3.02M	0.39%	42

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Senvest Management's TEVA Position: Q3 2015 in Review

Senvest Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 7,028 shares — an estimated $415K sold.

Senvest Management first reported a position in TEVA in Q2 2013 and held it in 7 quarters. The position peaked at $3.04M in Q2 2013. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

Senvest Management reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Senvest Management sold 7,028 Teva Pharmaceuticals shares in Q3 2015, an estimated $415K.
Senvest Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Senvest Management's Teva Pharmaceuticals position peaked at $3.04M in Q2 2013.
823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Senvest Management's 13F filing for Q3 2015, filed 16 Nov 2015.